<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Nasal Peptide Delivery</title>
    <link>https://www.nasalpeptidedelivery.com/</link>
    <description>The Science of How Peptides Reach Their Target</description>
    <language>en-us</language>
    <lastBuildDate>Sun, 28 Jun 2026 13:09:53 +0000</lastBuildDate>
    <atom:link href="https://www.nasalpeptidedelivery.com/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Nasal Peptide Delivery Research: Mechanisms, Absorption, and Applications</title>
      <link>https://www.nasalpeptidedelivery.com/nasal-peptide-delivery-research/</link>
      <guid isPermaLink="true">https://www.nasalpeptidedelivery.com/nasal-peptide-delivery-research/</guid>
      <description>A research overview of nasal peptide delivery — absorption mechanisms, mucosal permeation, bioavailability data, and formulation factors from published pre-clinical studies.</description>
      <pubDate>Sat, 27 Jun 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Nasal Mucosa as a Drug Delivery Route: Anatomy and Absorption Science</title>
      <link>https://www.nasalpeptidedelivery.com/nasal-mucosa-anatomy-drug-delivery/</link>
      <guid isPermaLink="true">https://www.nasalpeptidedelivery.com/nasal-mucosa-anatomy-drug-delivery/</guid>
      <description>How the nasal mucosa functions as a drug delivery route — anatomy, blood supply, lymphatic drainage, and what makes it useful for peptide absorption research.</description>
      <pubDate>Sat, 27 Jun 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Peptide Molecular Weight and Nasal Absorption: What the Research Shows</title>
      <link>https://www.nasalpeptidedelivery.com/peptide-molecular-weight-nasal-absorption/</link>
      <guid isPermaLink="true">https://www.nasalpeptidedelivery.com/peptide-molecular-weight-nasal-absorption/</guid>
      <description>How peptide molecular weight affects nasal absorption — permeation thresholds, size exclusion effects, and published data on large vs small peptide delivery across nasal mucosa.</description>
      <pubDate>Sat, 27 Jun 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Intranasal Insulin Research: CNS Delivery Without Systemic Effects</title>
      <link>https://www.nasalpeptidedelivery.com/intranasal-insulin-research-cns-delivery/</link>
      <guid isPermaLink="true">https://www.nasalpeptidedelivery.com/intranasal-insulin-research-cns-delivery/</guid>
      <description>Pre-clinical and early human research on intranasal insulin delivery — how it bypasses systemic circulation to reach the CNS, and what studies show about cognitive and metabolic effects.</description>
      <pubDate>Sat, 27 Jun 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Nasal Absorption Enhancers in Peptide Delivery Research</title>
      <link>https://www.nasalpeptidedelivery.com/nasal-absorption-enhancers-peptides/</link>
      <guid isPermaLink="true">https://www.nasalpeptidedelivery.com/nasal-absorption-enhancers-peptides/</guid>
      <description>Research on nasal absorption enhancers — chitosan, cyclodextrins, surfactants, and tight junction modulators studied to improve peptide bioavailability across nasal mucosa.</description>
      <pubDate>Sat, 27 Jun 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>BPC-157 Intranasal Delivery: What Administration Route Research Shows</title>
      <link>https://www.nasalpeptidedelivery.com/bpc-157-intranasal-delivery-research/</link>
      <guid isPermaLink="true">https://www.nasalpeptidedelivery.com/bpc-157-intranasal-delivery-research/</guid>
      <description>Review of BPC-157 administration route research including nasal delivery considerations — bioavailability comparisons across subcutaneous, oral, and intranasal routes in animal models.</description>
      <pubDate>Sat, 27 Jun 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Semax Intranasal Delivery: Russian Research and Bioavailability Studies</title>
      <link>https://www.nasalpeptidedelivery.com/semax-intranasal-delivery-research/</link>
      <guid isPermaLink="true">https://www.nasalpeptidedelivery.com/semax-intranasal-delivery-research/</guid>
      <description>Review of published research on Semax nasal delivery — the Russian neuropeptide developed for intranasal use, its formulation, CNS uptake data, and what pre-clinical studies show.</description>
      <pubDate>Sat, 27 Jun 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Selank Nasal Administration: Bioavailability and Pharmacokinetic Research</title>
      <link>https://www.nasalpeptidedelivery.com/selank-nasal-administration-bioavailability/</link>
      <guid isPermaLink="true">https://www.nasalpeptidedelivery.com/selank-nasal-administration-bioavailability/</guid>
      <description>Pre-clinical and published research on Selank intranasal administration — how the anxiolytic peptide is delivered nasally, its pharmacokinetic profile, and bioavailability data.</description>
      <pubDate>Sat, 27 Jun 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Blood-Brain Barrier Bypass: Intranasal Peptide Delivery to the CNS</title>
      <link>https://www.nasalpeptidedelivery.com/blood-brain-barrier-intranasal-peptide-delivery/</link>
      <guid isPermaLink="true">https://www.nasalpeptidedelivery.com/blood-brain-barrier-intranasal-peptide-delivery/</guid>
      <description>How intranasal peptide delivery can bypass the blood-brain barrier — olfactory and trigeminal pathways, nose-to-brain transport mechanisms, and published pre-clinical evidence.</description>
      <pubDate>Sat, 27 Jun 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Subcutaneous vs Intranasal Peptide Delivery: Route Comparison Research</title>
      <link>https://www.nasalpeptidedelivery.com/subcutaneous-vs-intranasal-peptide-delivery/</link>
      <guid isPermaLink="true">https://www.nasalpeptidedelivery.com/subcutaneous-vs-intranasal-peptide-delivery/</guid>
      <description>Pre-clinical comparison of subcutaneous and intranasal peptide delivery routes — bioavailability ratios, onset times, tissue distribution, and which route is studied for which compounds.</description>
      <pubDate>Sat, 27 Jun 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Peptide Stability in Nasal Formulations: Enzymatic Degradation Research</title>
      <link>https://www.nasalpeptidedelivery.com/peptide-stability-nasal-formulations/</link>
      <guid isPermaLink="true">https://www.nasalpeptidedelivery.com/peptide-stability-nasal-formulations/</guid>
      <description>How peptides degrade in nasal formulations — mucosal enzymes, pH effects, aminopeptidases, and formulation strategies studied to protect peptide stability during nasal delivery.</description>
      <pubDate>Sat, 27 Jun 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Cyclodextrins as Nasal Peptide Delivery Enhancers: Research Review</title>
      <link>https://www.nasalpeptidedelivery.com/cyclodextrin-nasal-peptide-delivery-enhancer/</link>
      <guid isPermaLink="true">https://www.nasalpeptidedelivery.com/cyclodextrin-nasal-peptide-delivery-enhancer/</guid>
      <description>Research on cyclodextrins as nasal delivery enhancers for peptides — solubility improvement, permeation enhancement mechanisms, and published bioavailability data from formulation studies.</description>
      <pubDate>Sat, 27 Jun 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>PT-141 (Bremelanotide) Nasal Delivery: From Research Peptide to Clinical Study</title>
      <link>https://www.nasalpeptidedelivery.com/pt-141-bremelanotide-nasal-research/</link>
      <guid isPermaLink="true">https://www.nasalpeptidedelivery.com/pt-141-bremelanotide-nasal-research/</guid>
      <description>History and science of PT-141 (bremelanotide) as a nasally delivered melanocortin peptide — original pre-clinical research, route transition to subcutaneous, and what the delivery science shows.</description>
      <pubDate>Sat, 27 Jun 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Mucociliary Clearance and Peptide Nasal Delivery: Residence Time Research</title>
      <link>https://www.nasalpeptidedelivery.com/nasal-mucociliary-clearance-peptide-delivery/</link>
      <guid isPermaLink="true">https://www.nasalpeptidedelivery.com/nasal-mucociliary-clearance-peptide-delivery/</guid>
      <description>How mucociliary clearance affects nasal peptide delivery — residence time limitations, formulation strategies to extend contact, and published data on clearance rates and peptide absorption windows.</description>
      <pubDate>Sat, 27 Jun 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Chitosan in Nasal Peptide Delivery: Mucoadhesion and Absorption Enhancement</title>
      <link>https://www.nasalpeptidedelivery.com/chitosan-nasal-peptide-delivery-research/</link>
      <guid isPermaLink="true">https://www.nasalpeptidedelivery.com/chitosan-nasal-peptide-delivery-research/</guid>
      <description>Research on chitosan as a nasal peptide delivery excipient — mucoadhesive properties, tight junction opening, charge interactions, and published bioavailability enhancement data.</description>
      <pubDate>Sat, 27 Jun 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Oxytocin and Vasopressin Intranasal Research: Neuropeptide Delivery Models</title>
      <link>https://www.nasalpeptidedelivery.com/oxytocin-vasopressin-intranasal-research/</link>
      <guid isPermaLink="true">https://www.nasalpeptidedelivery.com/oxytocin-vasopressin-intranasal-research/</guid>
      <description>Pre-clinical and human research on intranasal oxytocin and vasopressin delivery — CNS uptake pathways, behavioral study designs, and what the pharmacokinetic data reveals about neuropeptide nasal delivery.</description>
      <pubDate>Sat, 27 Jun 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Growth Hormone Secretagogues: Nasal vs Injectable Delivery Research</title>
      <link>https://www.nasalpeptidedelivery.com/gh-secretagogues-nasal-delivery-research/</link>
      <guid isPermaLink="true">https://www.nasalpeptidedelivery.com/gh-secretagogues-nasal-delivery-research/</guid>
      <description>Pre-clinical comparison of nasal vs injectable delivery for growth hormone secretagogues — bioavailability ratios, GH response differences, and formulation challenges studied in animal models.</description>
      <pubDate>Sat, 27 Jun 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Nasal pH and Peptide Absorption: Formulation and Ionization Research</title>
      <link>https://www.nasalpeptidedelivery.com/nasal-ph-peptide-absorption-research/</link>
      <guid isPermaLink="true">https://www.nasalpeptidedelivery.com/nasal-ph-peptide-absorption-research/</guid>
      <description>How nasal cavity pH affects peptide absorption — ionization states, mucosal charge interactions, formulation pH optimization, and published data on how pH manipulation changes bioavailability.</description>
      <pubDate>Sat, 27 Jun 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Nanoparticle-Based Nasal Peptide Delivery: Research on Encapsulation Systems</title>
      <link>https://www.nasalpeptidedelivery.com/nasal-nanoparticle-peptide-delivery-research/</link>
      <guid isPermaLink="true">https://www.nasalpeptidedelivery.com/nasal-nanoparticle-peptide-delivery-research/</guid>
      <description>Pre-clinical research on nanoparticle systems for nasal peptide delivery — PLGA, lipid nanoparticles, polymeric micelles, and what encapsulation does to absorption and mucosal permeation.</description>
      <pubDate>Sat, 27 Jun 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Peptide Bioavailability: Comparing Nasal, Oral, Subcutaneous, and IP Routes</title>
      <link>https://www.nasalpeptidedelivery.com/peptide-bioavailability-route-comparison-research/</link>
      <guid isPermaLink="true">https://www.nasalpeptidedelivery.com/peptide-bioavailability-route-comparison-research/</guid>
      <description>Pre-clinical data comparing peptide bioavailability across nasal, oral, subcutaneous, and intraperitoneal administration routes — what the published pharmacokinetic research shows about route selection.</description>
      <pubDate>Sat, 27 Jun 2026 00:00:00 +0000</pubDate>
    </item>
  </channel>
</rss>